Literature DB >> 11680586

Effect of exogenous cholecystokinin and secretin on pancreatic secretion of insulin and glucagon in rats: in vivo model without hepatic filter.

R L Ferrer1, J Medrano, R Calpena, M Diego, M L Graells, M V Molto, M T Pérez, M I Oliver, G M Salido.   

Abstract

In order to study the effect of cholecystokinin and secretin on the endocrine function of the pancreas, we have developed an experimental model that we have applied to a total of 30 anesthetized rats stimulated with physiological or supraphysiological doses of cholecystokinin and secretin administered intravenously by continuous infusion. Our results show that the serum insulin concentration increases after the supramaximum dose of cholecystokinin is infused, while that of glucagon increases after the maximum dose of this hormone. In case of secretin, the serum glucagon level increases after the supramaximum dose, while that of insulin is not affected by any dose. We conclude that after infusion of physiological doses of cholecystokinin, the pancreatic secretion of glucagon is modified but not that of insulin, while secretin has no effect on the endocrine pancreatic secretion of either insulin or glucagon upon the same conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11680586     DOI: 10.1023/a:1011994327575

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  33 in total

Review 1.  Cholecystokinin and the regulation of insulin secretion.

Authors:  S Karlsson; B Ahrén
Journal:  Scand J Gastroenterol       Date:  1992       Impact factor: 2.423

2.  Biphasic insulin secretion after intravenous but not after intraportal CCK-8 infusion in rats.

Authors:  B Balkan; A B Steffens; J H Strubbe; J E Bruggink
Journal:  Diabetes       Date:  1990-06       Impact factor: 9.461

3.  Reference ranges for alpha-amylase in serum and urine with 4,6-ethylidene-(G7)-1-4-nitrophenyl-(G1)-alpha,D-maltoheptaoside as substrate.

Authors:  W Hohenwallner; W Stein; J C Hafkenscheid; J D Kruse-Jarres; C Kaiser; A Hubbuch; G Klein
Journal:  J Clin Chem Clin Biochem       Date:  1989-02

4.  [Blood glucose levels in capilary blood of adults assessed by the hexokinase method (author's transl)].

Authors:  F H Schmidt
Journal:  Klin Wochenschr       Date:  1973-05-15

5.  Pancreatic dose-response curves to intravenous secretin in man.

Authors:  S J Konturek
Journal:  Gastroenterology       Date:  1970-06       Impact factor: 22.682

6.  Augmented insulin responses to glucose after secretin priming in diabetic subjects.

Authors:  R L Lerner
Journal:  J Clin Endocrinol Metab       Date:  1979-03       Impact factor: 5.958

7.  Unresponsiveness of insulinoma cells to secretin: significance of the secretin test in patients with insulinoma.

Authors:  M Imamura; Y Hattori; O Nishida; T Honda; Y Shimada; T Miyahara; T Wagata; N Baba; T Tobe
Journal:  Pancreas       Date:  1990-07       Impact factor: 3.327

8.  [Study of exocrine pancreas function stimulated by secretin and CCK (cholecystokinin) in the dog].

Authors:  R Calpena Rico; J Medrano Heredia; J M Pardo Correcher; M Diego Estévez; J L Vázquez Rojas; F Candela Polo; J Barragán Ortiz; M J García Cortés; R Arrese Caballero
Journal:  Rev Esp Enferm Apar Dig       Date:  1987-05

9.  Pancreatic enzyme response to secretin and cholecystokinin-pancreozymin in the rat.

Authors:  U R Fölsch; K G Wormsley
Journal:  J Physiol       Date:  1973-10       Impact factor: 5.182

10.  Effects of three different cholecystokinin receptor antagonists on basal and stimulated insulin and glucagon secretion in mice.

Authors:  S Karlsson; B Ahrén
Journal:  Acta Physiol Scand       Date:  1989-03
View more
  1 in total

1.  Cholecystokinin and secretin and pancreatic secretion of insulin and glucagon.

Authors:  Fuad Lechin; Bertha van der Dijs; Beatriz Orozco
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.